PTH abnormalities in chronic kidney diseaseMitra NaseriNickan Research Institute
PTH and phosphate levels above KDIGO indices were associated with additional surgical intervention. Many patients had laboratory indices above range at the last follow up, suggesting more patients had persistent or recurrent disease than those who underwent reoperation. Patients may benefit from more ...
in chronic kidney disease patients there are three main stimuli for parathyroid hormone (pth) secretion by the chief cell in the parathyroid glands: hypocalcaemia, low 1,25(oh)2d3 levels and hyperphosphataemia. fgf23 is a regulator of phosphate and vitamin d metabolism. the discovery of fgf...
BACKGROUND: At present, there is a high incidence of elderly patients with advanced chronic kidney disease (CKD) and it is important to know the long term progression and the factors that influence it. OBJECTIVES: To analyse the progression of advanced CKD in elderly patients and the influence...
BACKGROUND: Aldosterone antagonists may mediate their effects on heart failure through parathyroid hormone (PTH) in chronic kidney disease (CKD) patients. METHODS: Patients with CKD on spironolactone were selected and matched for age, gender, race, use of a vitamin D analogue, the number of antih...
71Bone resorption and bone formation markers can be measured.72–77Data suggest that specific serum BTM levels including serum PTH may help to discriminate among the heterogeneous forms of renal bone disease;13–15,78–81and are valuable as well to assess systemic bone turnover in post-...
Pseudohypoparathyroidism (PHP) is a heterogenous disease complex characterized by resistance to parathyroid hormone (PTH). PHP type Ib has been thought to be caused by abnormalities in PTH/PTH-related protein (PTHrP) receptor. However, previous studies have shown no mutation in the coding region ...
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease Author links open overlay panelA. Levin 1, G.L. Bakris 2, M. Molitch 3, M. Smulders 4, J. Tian 5, L.A. Williams 5, ...
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients Calcimimetic agents lower abnormal serum parathyroid hormone (PTH) levels in people who have chronic kidney disease (CKD), but the benefits and harms on pa... AE Ballinger,SC Palmer,I Nistor,... - 《Cochrane Databa...
Chronic kidney disease (CKD), as defined by low levels of eGFR, is common and is a risk factor for premature cardiovascular disease (CVD). The risk rises incrementally with decline in eGFR and is maximal in patients with end-stage kidney disease (ESKD) requiring dialysis (to around 20 times...